Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rubio-Rivas

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|July 29, 2023
Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 RegistryManuel Méndez Bailón, Noel Lorenzo Villalba, Jorge Garcia Onrubia, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvementNerea Iniesta Arandia, Gerard Espinosa, Carles Tolosa Vilella, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Journal of General Internal Medicine|April 9, 2022
WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity ScalesManuel Rubio-Rivas, José María Mora-Luján, Francesc Formiga, et al.
Journal of Clinical Medicine|October 13, 2021
Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National RegistryDavid Balaz, Philip Erick Wikman-Jorgensen, Vicente Giner Galvañ, et al.
Journal of Clinical Medicine|April 12, 2022
Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 RegistryJose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, Almudena López-Sampalo, et al.
Journal of Clinical Medicine|April 30, 2021
Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 RegistryMaría Del Mar Ayala Gutiérrez, Manuel Rubio-Rivas, Carlos Romero Gómez, et al.
Clinical and Experimental Rheumatology|August 3, 2023
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survivalCarles Tolosa-Vilella, Maria Del Mar Rodero-Roldán, Alfredo Guillen-Del-Castillo, et al.
Journal of Clinical Medicine|October 23, 2021
Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective StudyAna Muñoz-Gómez, Ana Fernández-Cruz, Cristina Lavilla-Olleros, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 9, 2020
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illnessManuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|July 29, 2023
Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 RegistryManuel Méndez Bailón, Noel Lorenzo Villalba, Jorge Garcia Onrubia, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvementNerea Iniesta Arandia, Gerard Espinosa, Carles Tolosa Vilella, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Journal of General Internal Medicine|April 9, 2022
WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity ScalesManuel Rubio-Rivas, José María Mora-Luján, Francesc Formiga, et al.
Journal of Clinical Medicine|October 13, 2021
Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National RegistryDavid Balaz, Philip Erick Wikman-Jorgensen, Vicente Giner Galvañ, et al.
Journal of Clinical Medicine|April 12, 2022
Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 RegistryJose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, Almudena López-Sampalo, et al.
Journal of Clinical Medicine|April 30, 2021
Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 RegistryMaría Del Mar Ayala Gutiérrez, Manuel Rubio-Rivas, Carlos Romero Gómez, et al.
Clinical and Experimental Rheumatology|August 3, 2023
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survivalCarles Tolosa-Vilella, Maria Del Mar Rodero-Roldán, Alfredo Guillen-Del-Castillo, et al.
Journal of Clinical Medicine|October 23, 2021
Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective StudyAna Muñoz-Gómez, Ana Fernández-Cruz, Cristina Lavilla-Olleros, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 9, 2020
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illnessManuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, et al.
Pageof 9